Benign prostatic hyperplasia treatment market value to reach $5 billion by 2024
17 September 2015 | By Victoria White
The value of the global therapeutics market for benign prostatic hyperplasia will rise from $2 billion in 2014 to approximately $4.9 billion by 2024...